NO20031844L - Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav - Google Patents

Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav

Info

Publication number
NO20031844L
NO20031844L NO20031844A NO20031844A NO20031844L NO 20031844 L NO20031844 L NO 20031844L NO 20031844 A NO20031844 A NO 20031844A NO 20031844 A NO20031844 A NO 20031844A NO 20031844 L NO20031844 L NO 20031844L
Authority
NO
Norway
Prior art keywords
processes
preparation
ascorbic acid
acid compounds
new ascorbic
Prior art date
Application number
NO20031844A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031844D0 (no
Inventor
Matthias Rath
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of NO20031844D0 publication Critical patent/NO20031844D0/no
Publication of NO20031844L publication Critical patent/NO20031844L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20031844A 2001-08-24 2003-04-24 Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav NO20031844L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31485701P 2001-08-24 2001-08-24
PCT/EP2002/009451 WO2003018568A2 (fr) 2001-08-24 2002-08-23 Nouveaux composes d'acide ascorbique, leurs procedes de synthese et leur utilisation

Publications (2)

Publication Number Publication Date
NO20031844D0 NO20031844D0 (no) 2003-04-24
NO20031844L true NO20031844L (no) 2003-06-12

Family

ID=23221754

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031844A NO20031844L (no) 2001-08-24 2003-04-24 Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav

Country Status (19)

Country Link
US (2) US6864284B2 (fr)
EP (3) EP1423375A2 (fr)
JP (1) JP4162593B2 (fr)
KR (1) KR20040044472A (fr)
CN (3) CN100378087C (fr)
BR (1) BR0205944A (fr)
CA (1) CA2458344A1 (fr)
HR (1) HRP20040207A2 (fr)
HU (1) HUP0600084A2 (fr)
IL (4) IL155578A0 (fr)
MX (1) MXPA04001655A (fr)
NO (1) NO20031844L (fr)
NZ (3) NZ542240A (fr)
PL (1) PL373522A1 (fr)
RU (1) RU2309152C2 (fr)
UA (1) UA78223C2 (fr)
WO (2) WO2003018568A2 (fr)
YU (1) YU38103A (fr)
ZA (1) ZA200304712B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067890A1 (en) * 2002-10-04 2004-04-08 Gupta Shyam K. Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions
CN1805948A (zh) * 2003-04-21 2006-07-19 塔格拉生物科技有限公司 抗坏血酸的稳定衍生物
CN100346782C (zh) * 2004-05-21 2007-11-07 北京京卫信康医药科技发展有限公司 一种含氨基酸的维生素c组合物
KR100544159B1 (ko) * 2004-07-14 2006-01-24 센양 뉴라이프 인더스트리알 코 엘티디 아스코르빌 테트라이소팔미테이트와 디팔미토일하이드록시프롤린을 함유한 나노 에멀젼 및 이를함유하는 화장료 조성물
US20070002866A1 (en) * 2005-06-29 2007-01-04 Denso Corporation Receive power priority flooding in mobile ad hoc networks
UA100841C2 (en) 2006-02-21 2013-02-11 Мэри Кей, Инк. Normal;heading 1;heading 2;heading 3;STABLE VITAMIN C COMPOSITIONS
US20080188553A1 (en) * 2007-02-06 2008-08-07 Waheed M Roomi Novel ascorbic acid compounds, methods of synthesis and application use thereof
FR2913686B1 (fr) * 2007-03-14 2009-05-01 Oreal Nouveaux composes carbamates de vitamine c, compositions les comprenant, et utilisations
US8828960B2 (en) * 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
EP3478259A4 (fr) * 2016-06-29 2020-02-26 Orasis Medical, Inc. Conjugués acide ascorbique-acide aminé et leur utilisation dans la régulation d'écoulement de fluide
CN111148525B (zh) * 2017-09-15 2024-07-05 凯恩塞恩斯株式会社 作为自身免疫疾病及骨病治疗剂的肽的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1273989A (fr) * 1960-09-09 1961-10-20 Marbou Procédé de préparation de l'ascorbate de lysine
US4424232A (en) * 1982-05-19 1984-01-03 Parkinson Richard W Treatment of herpes simplex
US4518614A (en) * 1982-11-04 1985-05-21 Redken Laboratories, Inc. Cosmetic preparation
JPS63190882A (ja) * 1987-02-03 1988-08-08 Nippon Haipotsukusu:Kk アスコルビン酸誘導体及びそれを含有する皮膚脱色剤並びにその製造法
FR2650180B1 (fr) * 1989-07-31 1995-03-03 Chisso Corp Procede de production d'une feuille facilement soluble dans l'eau a base d'acide hyaluronique ou de hyaluronate et feuille ainsi obtenue
EP0532706B1 (fr) * 1990-06-04 1995-05-10 Health Now REDUCTION D'OCCLUSIONS DE VAISSEAUX CARDIOVASCULAIRES A L'AIDE D'ASCORBATE ET D'INHIBITEURS DE LIAISON DE LA LIPOPROTEINE (a)
JPH04247011A (ja) * 1991-02-04 1992-09-03 Q P Corp リン脂質系アスコルビン酸誘導体及び該誘導体を含む皮膚外用剤
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
JPH0666958A (ja) * 1991-08-29 1994-03-11 Masaki Yoshigaki 目覚し時計の目覚し設定並びに目覚し音停止機構
JPH0678560A (ja) * 1992-08-26 1994-03-18 Matsushita Electric Works Ltd インバータ装置
FR2715156B1 (fr) 1994-01-20 1996-03-01 Oreal Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
US5626883A (en) * 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity
US5951990A (en) 1995-05-15 1999-09-14 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US5607968A (en) 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates
FR2737971B1 (fr) 1995-08-25 1997-11-14 Lvmh Rech Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
US6162419A (en) 1996-11-26 2000-12-19 Nicholas V. Perricone Stabilized ascorbyl compositions
US5962517A (en) * 1997-01-31 1999-10-05 Murad; Howard Pharmaceutical compositions and methods for treating acne
EP0891771A1 (fr) 1997-07-08 1999-01-20 Health Now, Inc. Compositions comprenant du lysine et d'ascorbate ou ses dérivés pour le traitement de troubles cardiovasculaires

Also Published As

Publication number Publication date
IL176523A0 (en) 2006-10-05
IL176524A0 (en) 2006-10-05
EP2241559A3 (fr) 2014-07-09
IL155578A0 (en) 2003-11-23
EP1423375A2 (fr) 2004-06-02
JP2005501867A (ja) 2005-01-20
CN100378087C (zh) 2008-04-02
US20030119753A1 (en) 2003-06-26
WO2003018568A3 (fr) 2003-12-04
ZA200304712B (en) 2004-07-12
US20040167077A1 (en) 2004-08-26
CN1763028A (zh) 2006-04-26
HRP20040207A2 (en) 2005-02-28
CN1518545A (zh) 2004-08-04
KR20040044472A (ko) 2004-05-28
MXPA04001655A (es) 2004-05-31
US7230124B2 (en) 2007-06-12
NZ542241A (en) 2006-09-29
NO20031844D0 (no) 2003-04-24
EP2241560A2 (fr) 2010-10-20
NZ531430A (en) 2006-05-26
EP2241559A2 (fr) 2010-10-20
WO2003018568A2 (fr) 2003-03-06
CN100360514C (zh) 2008-01-09
IL155578A (en) 2006-12-10
YU38103A (sh) 2006-05-25
PL373522A1 (en) 2005-09-05
RU2309152C2 (ru) 2007-10-27
JP4162593B2 (ja) 2008-10-08
US6864284B2 (en) 2005-03-08
HUP0600084A2 (en) 2006-06-28
BR0205944A (pt) 2004-12-28
WO2003018000A1 (fr) 2003-03-06
CN100361987C (zh) 2008-01-16
EP2241560A3 (fr) 2014-07-09
RU2004108687A (ru) 2005-09-20
CN1763027A (zh) 2006-04-26
NZ542240A (en) 2006-09-29
CA2458344A1 (fr) 2003-03-06
UA78223C2 (uk) 2007-03-15

Similar Documents

Publication Publication Date Title
NO20015113D0 (no) Nye forbindelser, deres fremstilling og anvendelse
NO20040680L (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20030301D0 (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
NO20035325D0 (no) Hudpermeabelt selektiv cyklooksygenase-2-inhibitorpreparat
DK1423376T3 (da) Bicyklisk forbindelse, fremstilling og anvendelse deraf
DK1414809T3 (da) Indaneddikesyrederivater og anvendelse deraf som farmaceutiske midler, mellemprodukter og fremgangsmåder til fremstilling deraf
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
NO20034187D0 (no) Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer
NO20031273L (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
NO20034970D0 (no) Nye arylheteroalkylaminderivater
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
NO20025029D0 (no) Nye epotilonderivater, fremgangsmåte for fremstilling derav og deres farmasöytiske anvendelse
IS7491A (is) Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
NO20052124D0 (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
IL176523A0 (en) Ascorbic acid compounds, methods of synthesis and application use thereof
NO20043349L (no) Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
NO20041185L (no) Nye sykloheksylsulfoner
NO20033120L (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application